Modulation of doxorubicin sensitivity by a novel organic compound, oxalyl bis ( N-phenyl) hydroxamic acid on acetyl aminofluorene-induced preneoplastic hepatocytes

Cancer Letters

Volumn 202, Issue 1, 2003, Pages 25-34

  Choudhuri, S K ^a   Majumder, Surajit ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Doxorubicin (Dox); Modulators; Oxalyl bis (N phenyl) hydroxamic acid (OBPHA); Sensitivity

Indexed keywords

ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; DOXORUBICIN; ETACRYNIC ACID; FUNCTIONAL GROUP; GLYCOPROTEIN P; HYDROXAMIC ACID DERIVATIVE; N (2 FLUORENYL)ACETAMIDE; OXALYLBIS(N PHENYL)HYDROXAMIC ACID; SUCCINYLBIS(N PHENYL)HYDROXAMIC ACID; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LIVER CELL; MALE; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

EID: 0345258495     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00474-9     Document Type: Article

References (29)

1. Bud G.T., Flemming R.M., Bukowski R.M., Mc Cracken J.D., Rivkin S.E., O'Bryan R.M., et al. 5-fluorouracil and folonic acid in the treatment of advanced colorectal cancer. J. Clin. Oncol. 5:1987;272-277.
2. Hidalgo O.F., Gonzalez F., Gil A., Camphell W., Barrajon E., Lacave A.J. 120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer. Am. J. Clin. Oncol. 12:1989;397-401.
3. Sadzuka Y., Mochizuki E., Iwazaki A., Hirota S., Takino Y. Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma-bearing mice. Biol. Pharm. Bull. 18:1995;159-161.
4. Sadzuka Y., Iwazaki A., Miyagishima A., Nozawa Y., Hirota S. Effect of methyl zanthene derivatives on adriamycin concentration and antitumor activity. Jpn. J. Cancer Res. 86:1995;594-599.
5. Choudhuri S.K., Chatterjee R., Roy Chowdhury J. In vitro sensitivity of rat pre-neoplastic, neoplastic and normal hepatocytes to different metal and non-metal ions. Med. Sci. Res. 20:1992;267-269.
6. Choudhuri S.K. Antitumor properties of ascorbic acid in combination with stannous chloride and boric acid. Med. Sci. Res. 22:1994;791-792.
7. Choudhuri S.K., Chatterjee A. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis ( N -phenyl) hydroxamic acid in vitro. Anti Cancer Drugs. 9:1998;825-832.
8. Choudhuri S.K. Deactivation of P-glycoprotein by a newly developed hydroxamic derivative, oxalyl bis ( N -phenyl) hydroxamic acid in vitro. Neoplasma. 49:(4):2002;272-277.
9. Choudhuri S.K., Roy P.S., Ghosh A.K. Oxalyl-bis ( N -phenyl/ N -p-tolyl) hydroxamic acids as coordinating ligands: coordination compounds with organotins. Indian J. Chem. 23:1984;917-919.
10. Lecureur V., Guillouzo A., Fardel O. Differential regulation of mdr genes in response to 2-acetyl aminofluorene treatment in cultured rat and human hepatocytes. Carcinogenesis. 17:1996;1157-1160.
11. Ghosh N.N., Sarker D.K. Preparation and characterization of succinyl bis ( N -phenyl) hydroxamic acid. J. Indian Chem. Soc. 45:1968;550-552.
12. Epstein S., Ito N., Merkow L., Farber E. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism. Cancer Res. 27:1967;1702-1711.
13. Mitaka T., Furukawa F., Tsukada H. Effect of cholesteryl hemicuccinate on phalloidin sensitivity of normal and preneoplastic rat hepatocytes. Tumor Res. 23:1988;60.
14. Kreamer B.L., Steaker J.L., Sawada N., Sattler G.L. Use of low speed, isodensity percoll centrifugation method to increase the viability of isolated rat hepatocytes preparation. In vitro Cell Devl. Biol. 22:1986;201-211.
15. Kueng W., Silber E., Eppenberer U. Quantifiation of cells cultured on 96 well plates. Anal. Biochem. 182:1989;16-19.
16. Angelis P.D., Stokke T., Smedshammer L., Lothe R.A., Lehne G., Chen Y., Clausen O.P.F. P-glycoprotein is not expressed in majority of colorectal carcinomas and is not regulated by mutant p53 in vivo. British J. Cancer. 72:1995;307-311.
17. Lowry O.H., Rosenberg N.J., Farr A.L., Randal R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 196:1951;265-271.
18. Laemmli U. Clevage of structural proteins during the assembly of the head of bacteriofage T4. Nature. 227:1970;680-685.
19. Towbin H., Stachlin T., Gorden J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1976;4350-4354.
20. Chen C.J., Chin J.E., Ueda K., Clark D.P., Gottesman M.M., Roninson I.B. Internal duplication and homology with bacterial transport proteins in the mdr-I (P-glycoprotein) gene from multidrug resistant human cells. Cell. 47:1986;381-389.
21. 6-alkyl guanine-DNA-alkyl transferase as potential indicators of constitutive drug resistance in human colorectal tumours. Cancer Res. 51:1991;2092-2097.
22. Sedlack J., Lindsay R.N. Estimation of total protein bound and non protein sulphohydral groups in tissues in Ellmans reagent. Anal. Biochem. 25:1968;192-205.
23. Akoto T., Sawada N., Sattler G.L., Kleinman H.K., Pitot H.C. The control of DNA synthesis in primary cultures of hepatocytes from adult and young rats: interactions of extracelular matrix components, epidermal growth factor and the cell cycle. J. Cell Physiol. 130:1987;221-227.
24. Tsukada T., Mochizuki Y. Peroxisomes in hepatoma and hepatocarcinogenesis. Marchaloris M. Cancer Biology reviews. vol. 3:1982;16 Dekker, New York.
25. Sadzuka Y., Iwazaki A., Sugiyama T., Sawanishi T., Miyamoto K. 1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin. Jpn. J. Cancer Res. 89:1998;228-233.
26. van't Riet B., Wamper G.L., Elford H.L. Synthesis of hydroxy and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity. J. Med. Chem. 22:1979;589-591.
27. Sheilds H. Hydroxamic acids as a radiation damage trap. Radiat. Res. 100:1984;418-420.
28. Pallante S.L., Lisek C.A., Dulik D.M., Fenselau C. Glutathione conjugate. Immobilized enzyme synthesis and characterization by fast atom bombardment mass spectrometry. Drug Metab. Dispos. 14:1986;313-318.
29. Plomen J.H.T.M., van Ommen B., van Bladeren P.J. Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its conjugate. Biochem. Pharm. 40:1990;1631-1635.